This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donahoo, W. T. Articles by Eckel, R. H. Search for Related Content PubMed PubMed Citation Articles by Donahoo, W. T. Articles by Eckel, R. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Isoproterenol and Somatostatin Decrease Plasma Leptin in Humans: A Novel Mechanism Regulating Leptin Secretion¹

Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, 80262

Address all correspondence and requests for reprints to: Robert H. Eckel, Box B-151, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, Colorado 80262. E-mail: robert.eckel{at}uchsc.edu

In cultured adipocytes, leptin is increased by insulin and decreased by cAMP. In animal models, insulin and agents that increase intracellular cAMP have been shown to similarly affect plasma leptin in vivo. This study was undertaken to test the hypothesis that in humans increased cAMP induced by isoproterenol would decrease leptin. Five groups of normal weight subjects were studied: 1) subjects infused with isoproterenol at a rate of 24 ng/kg/min (ISO24); 2) subjects infused with isoproterenol at a rate of 8 ng/kg/min (ISO8); 3) subjects infused with somatostatin/insulin/GH followed by coinfusion with 8 ng/kg/min isoproterenol (ISO8 + SRIH); 4) subjects infused with somatostatin/insulin/GH alone (SRIH); and 5) control subjects infused with saline (NS). ISO24 infusion resulted in a 27% decrease in plasma leptin over 120 min. ISO24 also increased plasma insulin over the infusion. ISO8 resulted in a 16% decrease in leptin. Saline did not change leptin. SRIH alone decreased leptin 19% over the first 120 min, however no additional fall was seen over the next 120 min the SRIH group. Nonetheless, the addition of 8 ng/kg/min ISO during the second 120 min (ISO8 + SRIH) caused a 15% further decline in plasma leptin. Therefore both isoproterenol and somatostatin reduce plasma leptin in humans. The effect of isoproterenol is likely mediated by ß-adrenergic receptors, whereas the effect of somatostatin suggests a novel mechanism for the regulation of leptin.

This article has been cited by other articles:

				C. Corino, G. Pastorelli, F. Rosi, V. Bontempo, and R. Rossi Effect of dietary conjugated linoleic acid supplementation in sows on performance and immunoglobulin concentration in piglets J Anim Sci, July 1, 2009; 87(7): 2299 - 2305. [Abstract] [Full Text] [PDF]

				Q. Huang, X. Zhang, Z.-W. Jiang, B.-Z. Liu, N. Li, and J.-S. Li Hypoleptinemia in Gastric Cancer Patients: Relation to Body Fat Mass, Insulin, and Growth Hormone JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4): 229 - 235. [Abstract] [Full Text] [PDF]

				M. R. Ricci, M.-J. Lee, C. D. Russell, Y. Wang, S. Sullivan, S. H. Schneider, R. E. Brolin, and S. K. Fried Isoproterenol decreases leptin release from rat and human adipose tissue through posttranscriptional mechanisms Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E798 - E804. [Abstract] [Full Text] [PDF]

				K. Spiegel, R. Leproult, M. L'Hermite-Baleriaux, G. Copinschi, P. D. Penev, and E. Van Cauter Leptin Levels Are Dependent on Sleep Duration: Relationships with Sympathovagal Balance, Carbohydrate Regulation, Cortisol, and Thyrotropin J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5762 - 5771. [Abstract] [Full Text] [PDF]

				D. Seboek, P. Linscheid, H. Zulewski, I. Langer, M. Christ-Crain, U. Keller, and B. Muller Somatostatin Is Expressed and Secreted by Human Adipose Tissue upon Infection and Inflammation J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4833 - 4839. [Abstract] [Full Text] [PDF]

				K.-H. Jeong, S. Sakihara, E. P. Widmaier, and J. A. Majzoub Impaired Leptin Expression and Abnormal Response to Fasting in Corticotropin-Releasing Hormone-Deficient Mice Endocrinology, July 1, 2004; 145(7): 3174 - 3181. [Abstract] [Full Text] [PDF]

				K.-Y. Guo, P. Halo, R. L. Leibel, and Y. Zhang Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R112 - R119. [Abstract] [Full Text] [PDF]

				P. Chen, S. M. Williams, K. L. Grove, and M. S. Smith Melanocortin 4 Receptor-Mediated Hyperphagia and Activation of Neuropeptide Y Expression in the Dorsomedial Hypothalamus during Lactation J. Neurosci., June 2, 2004; 24(22): 5091 - 5100. [Abstract] [Full Text] [PDF]

				A. E. Kitabchi and G. E. Umpierrez Changes in Serum Leptin in Lean and Obese Subjects with Acute Hyperglycemic Crises J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2593 - 2596. [Abstract] [Full Text] [PDF]

				N. Eikelis, M. Schlaich, A. Aggarwal, D. Kaye, and M. Esler Interactions Between Leptin and the Human Sympathetic Nervous System Hypertension, May 1, 2003; 41(5): 1072 - 1079. [Abstract] [Full Text] [PDF]

				M. Z. Strowski, M. Kohler, H. Y. Chen, M. E. Trumbauer, Z. Li, D. Szalkowski, S. Gopal-Truter, J. K. Fisher, J. M. Schaeffer, A. D. Blake, et al. Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis Mol. Endocrinol., January 1, 2003; 17(1): 93 - 106. [Abstract] [Full Text] [PDF]

				P. G. Cammisotto and L. J. Bukowiecki Mechanisms of leptin secretion from white adipocytes Am J Physiol Cell Physiol, July 1, 2002; 283(1): C244 - C250. [Abstract] [Full Text] [PDF]

				L. Ghizzoni, G. Mastorakos, M. E. Street, G. Mazzardo, A. Vottero, M. Vanelli, and S. Bernasconi Leptin, Cortisol, and GH Secretion Interactions in Short Normal Prepubertal Children J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3729 - 3734. [Abstract] [Full Text] [PDF]

				M. BUYSE, S. VIENGCHAREUN, A. BADO, and M. LOMBES Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes FASEB J, June 1, 2001; 15(8): 1357 - 1366. [Abstract] [Full Text] [PDF]

				C. D. Russell, M. R. Ricci, R. E. Brolin, E. Magill, and S. K. Fried Regulation of the leptin content of obese human adipose tissue Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E399 - E404. [Abstract] [Full Text] [PDF]

				S. K. Fried, M. R. Ricci, C. D. Russell, and B. Laferrere Regulation of Leptin Production in Humans J. Nutr., December 1, 2000; 130 (12): 3127S - 3131S. [Abstract] [Full Text] [PDF]

				M. B. HORLICK, M. ROSENBAUM, M. NICOLSON, L. S. LEVINE, B. FEDUN, J. WANG, R. N. PIERSON Jr., and R. L. LEIBEL Effect of Puberty on the Relationship between Circulating Leptin and Body Composition J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2509 - 2518. [Abstract] [Full Text]

				A. M. Rice, J. N. Fain, and S. A. Rivkees A1 Adenosine Receptor Activation Increases Adipocyte Leptin Secretion Endocrinology, April 1, 2000; 141(4): 1442 - 1445. [Abstract] [Full Text] [PDF]

				D R Murdoch, E Rooney, H J Dargie, D Shapiro, J J Morton, and J J V McMurray Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure Heart, September 1, 1999; 82(3): 352 - 356. [Abstract] [Full Text] [PDF]

				C. S. Mantzoros The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence Ann Intern Med, April 20, 1999; 130(8): 671 - 680. [Abstract] [Full Text] [PDF]

				G. Van den Berghe, P. Wouters, L. Carlsson, R. C. Baxter, R. Bouillon, and C. Y. Bowers Leptin Levels in Protracted Critical Illness: Effects of Growth Hormone-Secretagogues and Thyrotropin-Releasing Hormone J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3062 - 3070. [Abstract] [Full Text]